Associate Professor of Biomedical Engineering and Radiology
Northwestern University
Chicago, Illinois, United States
Laleh Golestani Rad, PhD is an Associate Professor of Radiology and Biomedical Engineering at Northwestern University. She received her doctoral training in electrical engineering from the École Polytechnique Fédérale de Lausanne (EPFL) and completed postdoctoral training in medical biophysics at the University of Toronto, followed by a postdoctoral fellowship in radiology at Harvard Medical School and Massachusetts General Hospital.
Dr. Golestani Rad’s background spans RF engineering, computational electromagnetics, and medical imaging. Her work has been particularly centered on MRI safety for vulnerable patient populations, including children, where conventional safety frameworks and device labeling often impose significant limitations on access to clinically important imaging. She holds joint appointments in engineering and radiology and conducts research that connects theoretical and computational electromagnetic analysis and imaging methodology development with clinically relevant MRI safety considerations. In addition to her academic role, Dr. Golestani Rad is the co-founder and President of InnoCerebral Technologies, a company dedicated to translating MRI safety and implant-aware imaging technologies into clinical practice.
Dr. Golestani Rad has held leadership roles within the International Society of Magnetic Resonance in Medicine, including service as Vice Chair and Chair of the MRI Safety Study Group. She has also contributed to professional working groups focused on establishing best practices for RF safety testing of experimental MRI hardware. Through these roles, she has been actively involved in shaping community-wide discussions on MRI safety as new imaging technologies and device classes continue to emerge. She is a frequent invited speaker at national and international scientific meetings, where she is known for presenting MRI safety concepts through an integrated engineering and clinical lens.
MR Safety Consideration (Lead Length, S-ICD)
Wednesday, February 4, 2026
11:10 AM - 11:20 AM
